Wearable sensing
An adjustable interface combines pressure-sensing elements and motion-sensing modules around live gait.
NUWAC is designed as a connected operating architecture—from calibrated movement sensing to clinician-guided feedback and structured session intelligence.
Follow the architectureThe layers are connected by a common session context. This keeps sensing, feedback, review, and research outputs aligned with the configured rehabilitation goal.
An adjustable interface combines pressure-sensing elements and motion-sensing modules around live gait.
Connection, calibration, session state, and feedback status are coordinated in one focused flow.
Configurable goals and protocols keep professional judgment upstream of system execution.
Vibrotactile guidance is designed to be understandable inside the movement itself.
Local-first execution and secure session infrastructure preserve continuity and organized review.
Structured outputs create a foundation for candidate biomarkers, clinical partnerships, and validation.
Wearable sensing captures pressure and movement within a patient-specific session context. Public materials intentionally omit patent-sensitive component details, geometry, and thresholds.
An adaptive decision layer interprets relevant movement events within configured protocols and boundaries. The architecture is designed to execute clinical intent, not generate unsupervised treatment decisions.
When a configured deviation pattern is recognized, a separately placeable feedback layer can deliver a timely vibrotactile cue without requiring constant visual attention.
Local execution, short-range communication, recovery-aware session handling, and secure infrastructure are designed to preserve what happened across the loop.
Session outputs can support clinician review, research analysis, digital biomarker exploration, and validation across future gait-related applications.
The platform is intended to operate within clinician-defined rehabilitation intent, patient-specific calibration, configurable goals, and explicit safety boundaries.
See the evidence strategyWe are building relationships with clinicians, researchers, rehabilitation organizations, strategic partners, and investors.